ADAM28
ADAM28, also known as a disintegrin and metalloproteinase domain-containing protein 28, is a member of the ADAM family of proteins. These proteins are characterized by their disintegrin and metalloproteinase domains, which are involved in a variety of biological processes including cell adhesion, cell fusion, and proteolysis.
Structure[edit]
ADAM28 is a type I transmembrane protein that consists of several distinct domains:
- Pro-domain: This domain is involved in the regulation of the protein's activity.
- Metalloproteinase domain: Responsible for the proteolytic activity of the protein, allowing it to cleave other proteins.
- Disintegrin domain: Plays a role in cell-cell and cell-matrix interactions.
- Cysteine-rich domain: Involved in protein-protein interactions.
- EGF-like domain: May play a role in cell signaling.
- Transmembrane domain: Anchors the protein in the cell membrane.
- Cytoplasmic tail: Involved in intracellular signaling pathways.
Function[edit]
ADAM28 is involved in several physiological and pathological processes:
- Cell Adhesion: The disintegrin domain of ADAM28 can interact with integrins on the cell surface, influencing cell adhesion and migration.
- Proteolysis: The metalloproteinase domain allows ADAM28 to cleave various substrates, including growth factors, cytokines, and other membrane proteins.
- Immune Response: ADAM28 has been implicated in modulating immune responses, potentially by processing cytokines or interacting with immune cells.
- Cancer: Overexpression of ADAM28 has been observed in certain types of cancer, suggesting a role in tumor progression and metastasis.
Clinical Significance[edit]
ADAM28 has been studied in the context of several diseases:
- Cancer: Elevated levels of ADAM28 have been associated with poor prognosis in cancers such as breast cancer and non-small cell lung cancer.
- Cardiovascular disease: ADAM28 may play a role in atherosclerosis by influencing the behavior of vascular cells.
- Inflammatory diseases: Due to its role in modulating immune responses, ADAM28 may be involved in inflammatory conditions.
Research[edit]
Ongoing research is focused on understanding the precise mechanisms by which ADAM28 contributes to disease processes and exploring its potential as a therapeutic target. Inhibitors of ADAM28 are being investigated for their ability to block its activity and reduce disease progression.
Also see[edit]
| ADAM Family | |
|---|---|
|
A Disintegrin and Metalloproteinase |
|
| Members | |
| Functions | |
| Related Topics | |
| See Also | |
